Fluorescent magnetic nanopaticles-labeled murine embryonic stem cells for targeted identification of <italic>in vivo</italic> gastric cancer cells

2013 ◽  
Vol 58 (7) ◽  
pp. 593-600
Author(s):  
Chao LI ◽  
DaXiang CUI ◽  
Jing RUAN ◽  
Jun CHEN ◽  
Hua SONG
Theranostics ◽  
2012 ◽  
Vol 2 (6) ◽  
pp. 618-628 ◽  
Author(s):  
Jing Ruan ◽  
Hua Song ◽  
Chao Li ◽  
Chenchen Bao ◽  
Hualin Fu ◽  
...  

2013 ◽  
Vol 1 (1) ◽  
pp. 1
Author(s):  
Christine Finck ◽  
Blair Roszell ◽  
Todd Jensen ◽  
Ariel Seaton ◽  
Fan Zhang ◽  
...  

Blood ◽  
2009 ◽  
Vol 114 (2) ◽  
pp. 268-278 ◽  
Author(s):  
Shannon L. McKinney-Freeman ◽  
Olaia Naveiras ◽  
Frank Yates ◽  
Sabine Loewer ◽  
Marsha Philitas ◽  
...  

Abstract Surface antigens on hematopoietic stem cells (HSCs) enable prospective isolation and characterization. Here, we compare the cell-surface phenotype of hematopoietic repopulating cells from murine yolk sac, aorta-gonad-mesonephros, placenta, fetal liver, and bone marrow with that of HSCs derived from the in vitro differentiation of murine embryonic stem cells (ESC-HSCs). Whereas c-Kit marks all HSC populations, CD41, CD45, CD34, and CD150 were developmentally regulated: the earliest embryonic HSCs express CD41 and CD34 and lack CD45 and CD150, whereas more mature HSCs lack CD41 and CD34 and express CD45 and CD150. ESC-HSCs express CD41 and CD150, lack CD34, and are heterogeneous for CD45. Finally, although CD48 was absent from all in vivo HSCs examined, ESC-HSCs were heterogeneous for the expression of this molecule. This unique phenotype signifies a developmentally immature population of cells with features of both primitive and mature HSC. The prospective fractionation of ESC-HSCs will facilitate studies of HSC maturation essential for normal functional engraftment in irradiated adults.


2008 ◽  
Vol 18 (9-10) ◽  
pp. 759-760
Author(s):  
D. Ayub-Guerrieri ◽  
P.C.M. Martins ◽  
P.C.G. Onofre ◽  
V.F. Lopes ◽  
L.V. Pereira ◽  
...  

2015 ◽  
Vol 24 (21) ◽  
pp. 2547-2560 ◽  
Author(s):  
Maria A. Hoelzl ◽  
Karin Heby-Henricson ◽  
Ganna Bilousova ◽  
Björn Rozell ◽  
Raoul V. Kuiper ◽  
...  

2021 ◽  
Vol 11 ◽  
Author(s):  
Bin Chen ◽  
Tuo Cai ◽  
Chao Huang ◽  
Xueyan Zang ◽  
Li Sun ◽  
...  

Background: Tumor-associated stromal cells have been widely recognized for their tumor-promoting capability involving paracrine signaling. However, the underlying mechanism and the effects of the molecules in the glycolysis pathway in gastric cancer-associated mesenchymal stem cells (GCMSCs) and gastric cancer cells on tumor progression remain unclear.Methods: The expression of hepatocyte growth factor (HGF) in GCMSCs and bone marrow mesenchymal stem cells (BMMSCs) was detected by enzyme-linked immunosorbent assay (ELISA). The effect of HGF derived from GCMSCs on the proliferation, metastasis, and HK2 expression of gastric cancer cells was evaluated in vitro and in vivo. The effects of G6PD on the production of HGF in mesenchymal stem cells (MSCs) were analyzed by immunoblotting.Results: HGF derived from GCMSCs promoted glycolysis, proliferation, and metastasis of gastric cancer by upregulating c-Myc-HK2 signal. The progression of the disease induced by GCMSCs decelerated in the absence of HK2. The expression of G6PD activated NF-κB signaling and stimulated the production of HGF in GCMSCs. Blocking HGF derived from GCMSCs decreased proliferation, metastasis, and angiogenesis of gastric cancer cells in vivo.Conclusions: GCMSCs highly expressed G6PD and facilitated the progression of gastric cancer through the G6PD-NF-κB-HGF axis coordinates. Blocking HGF derived from GCMSCs is a potential new therapeutic target for the treatment of gastric cancer.


2012 ◽  
Vol 33 (2) ◽  
pp. e49-e54 ◽  
Author(s):  
Victoria F. Hamrahi ◽  
Jeremy Goverman ◽  
Walter Jung ◽  
Joseph C. Wu ◽  
Alan J. Fischman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document